Market Pulse

Event summary

• Mobilicom has secured a design win and initial order from an Israel-based drone manufacturer to integrate its SkyHopper PRO, SkyHopper PRO Lite, and Maxi Controller PRO into a new ISR drone platform.
• The ISR drone platform is slated for deployment in India, in collaboration with the Israeli manufacturer’s Indian partner.
• The order includes Mobilicom’s secure data links, ground control systems, and cybersecurity protections.
• The deal accelerates Mobilicom’s commercial footprint in the Asia-Pacific (APAC) region.

The big picture

What we're watching

Market Adoption

The success of this deployment in India will be a key indicator of Mobilicom’s ability to penetrate new markets and secure larger contracts within the ISR drone sector.

Competition

Increased competition in the ISR drone market may pressure Mobilicom’s pricing and margins, requiring ongoing innovation and differentiation.

Geopolitical Risk

The reliance on a partnership between an Israeli manufacturer and an Indian entity exposes Mobilicom to geopolitical tensions and potential disruptions in the region.

Event summary

• NovaBridge Biosciences appointed Emmett T. Cunningham, Jr., MD, PhD, MPH, as Vice Chairman of the Board, effective February 19, 2026.
• Dr. Cunningham is also Co-Founder and Executive Chairman of NovaBridge subsidiary, Visara, Inc., and will join the Board’s Research and Development Committee.
• Dr. Cunningham previously held senior roles at Blackstone Group L.P., Clarus Ventures, LLC, Eyetech, Inc., and Pfizer.
• He brings over 25 years of experience in venture capital, biopharma leadership, and directorship.

The big picture

What we're watching

R&D Focus

Dr. Cunningham’s involvement in the R&D Committee suggests a potential shift towards accelerated drug development timelines and a more aggressive innovation strategy, which could impact burn rates and pipeline progression.

Visara Synergy

The dual role at Visara and NovaBridge raises questions about potential resource allocation and strategic alignment between the two entities, and whether Visara’s assets will be prioritized.

Governance Dynamics

With a seasoned investor and former executive joining the board, NovaBridge’s governance structure may become more financially oriented, potentially influencing long-term strategic decisions and shareholder returns.

Event summary

• NetraMark Holdings Inc. completed a $3.5 million private placement, closing the final tranche on February 18, 2026.
• The placement involved the issuance of 3.5 million units at $1.00 per unit, with gross proceeds of $3.5 million.
• Each unit comprises one common share and a warrant to purchase an additional share at $1.35, expiring in two years.
• An insider subscribed for 232,500 units, constituting a related party transaction.
• The issuance increases NetraMark's outstanding common shares to 92,223,699.

The big picture

What we're watching

Governance Dynamics

The insider participation, coupled with the delayed filing of a material change report, warrants scrutiny of NetraMark's governance practices and potential conflicts of interest.

Capital Allocation

The stated use of proceeds for working capital and general corporate purposes is broad; investors should monitor how effectively this capital is deployed to drive revenue growth and profitability.

Warrant Dilution

The warrants issued as part of the placement will create potential dilution if exercised, and the pace at which these warrants are exercised will impact NetraMark's capital structure.

Event summary

• Cardiff Oncology management, including Interim CEO Mani Mohindru, will present at the Oppenheimer Healthcare Life Sciences Conference on February 25, 2026.
• The presentation will be a virtual event, accessible via webcast from Cardiff Oncology's website.
• Cardiff Oncology's lead asset, onvansertib, is in Phase 2 trials for first-line treatment of RAS-mutated metastatic colorectal cancer (mCRC).
• The company focuses on PLK1 inhibition, targeting a validated oncology target.

The big picture

What we're watching

Clinical Progress

The conference presentation will likely detail progress in the Phase 2 mCRC trial; investor reaction will hinge on any data updates or shifts in trial design.

Leadership Stability

The presence of an Interim CEO (Mani Mohindru) suggests ongoing leadership transition; the conference offers a chance to assess the long-term strategic direction under his guidance.

Market Adoption

The success of onvansertib will depend on its ability to overcome treatment resistance in a market crowded with existing therapies; the conference may reveal insights into adoption strategies.

Event summary

• Loblaw is integrating conversational AI shopping capabilities into Google Search and the Gemini app, allowing customers to purchase products directly.
• Loblaw is the first major Canadian retailer to offer this functionality through Google’s AI-mode.
• The collaboration leverages the emerging Universal Commerce Protocol (UCP) for secure transactions across channels.
• Loblaw is expanding its use of Google Cloud's Vertex AI platform to accelerate its AI-native transformation.
• Loblaw employs over 220,000 people, making it one of Canada’s largest private sector employers.

The big picture

What we're watching

UCP Adoption

The success of Loblaw’s integration hinges on the broader adoption of the Universal Commerce Protocol (UCP) by other retailers and platforms, which will determine the scalability of this new commerce stream.

Vertex AI Scale

Loblaw’s ability to effectively scale its use of Vertex AI will be crucial for realizing the promised operational efficiencies and improved customer experience, and will serve as a case study for other retailers.

Customer Migration

How effectively Loblaw can migrate existing customers to the AI-driven shopping experience will dictate the immediate impact on sales and overall customer satisfaction.

Event summary

• Bandwidth reported record fourth-quarter Adjusted EBITDA and free cash flow, alongside full-year results showing a slight revenue increase.
• The company is projecting 16% revenue growth and 29% Adjusted EBITDA growth for 2026.
• Bandwidth's board authorized an $80 million share repurchase program, signaling confidence in future performance.
• Key customer wins include a major U.S. insurance group, a top 10 bank, and a global automaker, all leveraging Bandwidth's AI-driven communications platform.
• Bandwidth is powering its first production RCS campaigns for a long-time customer, indicating expansion into emerging messaging technologies.

The big picture

What we're watching

Growth Sustainability

Whether Bandwidth can maintain its projected 16% revenue growth rate given the current macroeconomic climate and increasing competition in the cloud communications space.

AI Integration

How effectively Bandwidth integrates AI capabilities into its platform and whether this will translate into sustained customer acquisition and retention.

Capital Returns

The pace at which Bandwidth executes its share repurchase program and whether it will consider additional capital return initiatives as free cash flow grows.

Event summary

• Garrett Motion reported $891 million in net sales for Q4 2025, a 6% increase year-over-year, and $3,584 million for the full year 2025, up 3%.
• The company secured awards for E-powertrain and E-cooling technologies, with production slated to begin in 2027.
• Garrett repurchased $208 million of common shares in 2025, reducing share count by 8%, and authorized a new $250 million repurchase program.
• The company projects net sales between $3.6 and $3.8 billion for 2026, with a constant currency growth rate of -2% to +2%.

The big picture

What we're watching

Execution Risk

The ability to convert the growing pipeline of awards into actual revenue will be critical, particularly given the projected macroeconomic headwinds and potential for delayed production starts.

Margin Pressure

While margins improved in 2025, the outlook suggests potential pressure in 2026 due to foreign exchange fluctuations and pricing dynamics, requiring careful cost management.

EV Transition

The pace at which Garrett’s electrification technologies are adopted and integrated into vehicle production will determine its long-term growth trajectory, given the projected increase in battery electric vehicle penetration.

Event summary

• Tradr ETFs launched three new leveraged ETFs: CLSZ (2x Short CleanSpark), LEUX (2x Long Centrus Energy), and COHX (2x Long Coherent).
• The ETFs track the daily performance of CleanSpark, Centrus Energy, and Coherent, respectively, offering both long and inverse exposure.
• Tradr claims these are first-to-market strategies, building on the success of a previous leveraged ETF on CleanSpark (CLSX) launched in September 2025.
• Tradr ETFs currently manages over $2 billion in assets, spread across 69 leveraged ETFs.
• Tradr positions the ETFs as alternatives to margin and options trading for sophisticated investors.

The big picture

What we're watching

Performance Risk

The performance of these leveraged ETFs will be highly sensitive to the volatility of the underlying stocks, potentially leading to rapid and substantial losses, especially over longer time horizons.

Competitive Landscape

Other ETF providers may respond to Tradr’s first-mover advantage by launching competing leveraged products, potentially eroding Tradr’s market share and compressing margins.

Regulatory Scrutiny

The proliferation of leveraged ETFs may attract increased regulatory scrutiny regarding suitability for retail investors and potential systemic risks.

Event summary

• Canada Nickel and the University of Texas, funded by the U.S. Department of Energy’s ARPA-E, completed a pilot carbon sequestration project at the Crawford Nickel Project.
• The pilot successfully sequestered 12 tonnes of CO2 using an in-situ injection method.
• The project represents a third carbon storage pathway, distinct from Canada Nickel’s IPT Carbonation and NetCarb processes.
• The pilot was conducted between mid-November and mid-December 2025, injecting CO2-saturated water into a well drilled to 396m.

The big picture

What we're watching

Scalability

The long-term viability hinges on demonstrating the ability to scale this in-situ sequestration method beyond the pilot phase, considering geological variability and cost-effectiveness.

Regulatory Approval

Securing regulatory approvals for widespread in-situ carbon sequestration will be critical, as current frameworks may not fully address this novel approach.

Economic Impact

The potential for reduced mining costs through pre-conditioning and fracturing needs to be rigorously quantified and validated to justify broader adoption.

Event summary

• Freudenberg has extended its takeover offer period for Nilfisk Holding A/S until April 8, 2026, citing ongoing regulatory approval processes.
• Approximately 81.22% of Nilfisk shareholders have preliminarily accepted the offer, falling short of the acceptance condition.
• Regulatory clearance has been secured in the United States, while approvals from other jurisdictions remain pending.
• Freudenberg SE has acquired 4.9% of Nilfisk’s share capital as part of the offer.

The big picture

What we're watching

Regulatory Headwinds

The continued delays in securing remaining regulatory approvals suggest potential complications beyond initial estimates, which could impact the deal's timeline and ultimate success.

Acceptance Threshold

Whether Freudenberg can secure the remaining acceptances needed to satisfy the condition, particularly given the current level of acceptance and the extended timeline, remains a key uncertainty.

Integration Risk

Assuming the acquisition completes, the integration of Nilfisk's operations and product lines within Freudenberg's broader portfolio will be crucial for realizing anticipated synergies and avoiding operational disruptions.

Event summary

• Epson Robots, the world’s leading SCARA robot manufacturer, will exhibit at DesignCon, APEX Expo, and MAX in early 2026.
• The company will showcase its T-Series SCARA robot and Epson RC+ automation software at each event.
• Epson has sold over 150,000 robots globally and has 40 years of automation experience.
• DesignCon takes place February 24-26, 2026 in Santa Clara, APEX Expo March 17-19, 2026 in Anaheim, and MAX March 25-26, 2026 in Nashville.

The big picture

What we're watching

Market Positioning

Epson’s aggressive trade show presence suggests a renewed focus on SCARA robots as automation adoption expands beyond large enterprises, potentially intensifying competition within the segment.

Software Integration

The emphasis on Epson RC+ software indicates a strategy to differentiate through ease of use and integration, which will be critical for attracting smaller manufacturers and reducing deployment friction.

Geographic Expansion

Given Epson's stated goal of carbon neutrality and resource elimination by 2050, future expansion efforts will likely prioritize regions with supportive regulatory environments and sustainable manufacturing practices.

Event summary

• Brunswick achieved an 84% outboard engine share at the 2026 Miami International Boat Show, a 15-percentage point increase from 2025.
• The company’s outboard share rose nearly three percentage points across the entire show, reaching over 60%.
• Retail sales for premium brands Sea Ray, Boston Whaler, and Navan remained flat compared to a strong 2025 show.
• Brunswick introduced seven new products, including the Boston Whaler 290 and 330 Outrage models and the Simrad NSO 4 and B&G Zeus SRX multi-function displays.

The big picture

What we're watching

Market Dynamics

The flatness of sales for Sea Ray, Boston Whaler, and Navan, despite new product launches, suggests a potential softening in the premium boat segment that warrants further investigation.

Competitive Pressure

While Brunswick’s outboard share gains are impressive, sustained market leadership will depend on their ability to fend off competitive responses and maintain technological advantages.

Innovation Adoption

The success of Brunswick’s new technologies, like WhalerStep™ Hull Technology and the NEON operating system, will hinge on consumer adoption and perceived value relative to existing solutions.

Event summary

• Hydro-Québec is proposing new electricity rates for large data centers (over 5 MW) and blockchain operations.
• Data center rates will average 13¢/kWh, double the current rate for large-power customers, effective H2 2026 (pending approval).
• Blockchain rates will rise to an average of 19.5¢/kWh, also effective H2 2026 (pending approval), reflecting energy intensity.
• Québec anticipates data center electricity consumption to reach over 1,000 MW by 2035, a sevenfold increase.
• The move is backed by the government of Québec via Orders in Council and aims to prevent electricity bill increases for all customers, as seen in US jurisdictions.

The big picture

What we're watching

Regulatory Approval

The Régie de l'énergie’s decision on these rate changes will be critical, and any modifications could signal broader shifts in Québec’s energy policy.

Data Center Migration

How data center operators will respond to the higher rates, whether through relocation, efficiency improvements, or absorbing the costs, will impact Québec’s competitiveness.

Blockchain Impact

The significantly higher blockchain rates may curtail activity and innovation in the province, potentially shifting cryptographic operations to regions with more favorable energy pricing.

Event summary

• Serina Therapeutics initiated a Phase 1b registrational trial for SER-252, its apomorphine therapy for advanced Parkinson's disease.
• The first patient was enrolled in the trial, which is taking place in Australia.
• The trial aims to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of SER-252.
• Serina is proceeding on track for first patient dosing in Q1 2026, as previously indicated.
• The trial is designed to leverage a 505(b)(2) NDA pathway with FDA alignment.

The big picture

What we're watching

Enrollment Pace

The speed of patient enrollment across trial sites will be a key indicator of Serina's operational effectiveness and ability to meet trial timelines, particularly given the reliance on patient advocacy groups.

Regulatory Scrutiny

The FDA's ongoing assessment of Serina's 505(b)(2) development strategy and the data generated from this trial will dictate the path to potential commercialization and influence future development decisions.

Clinical Efficacy

Early efficacy data from the Phase 1b trial will be critical in validating the POZ Platform's ability to improve apomorphine delivery and reduce levodopa-related motor complications in Parkinson's patients.

Event summary

• First Atlantic Nickel has entered a two-stage earn-in agreement with Core Critical Metals Corp. for the Lucky Mike copper-silver-tungsten project in British Columbia.
• Core Critical Metals will invest up to $16 million to earn an 80% interest in the project over ten years.
• First Atlantic Nickel will retain a 20% participating interest, carried to feasibility, and a mining royalty.
• The Lucky Mike project is located near Teck Resources' Highland Valley copper mine and comprises 7,675 hectares.

The big picture

What we're watching

Execution Risk

Core Critical Metals’ ability to meet the staged expenditure requirements within the stipulated timelines will be critical to the agreement’s success and First Atlantic Nickel’s continued exposure to the project’s potential.

Financial Capacity

The financial health of Core Critical Metals will be under scrutiny, as the $16 million investment represents a significant commitment and requires securing additional funding.

Royalty Implications

The potential conversion of First Atlantic Nickel’s interest to a 3% NSR royalty if dilution occurs introduces a significant downside risk and will be a key factor in evaluating the long-term value of its retained stake.

Event summary

• Wishpond Technologies Ltd. is selling Viral Loops, a referral marketing software platform acquired in April 2022, to Emerge Commerce Ltd.
• The total cash consideration for the transaction is $2.3 million, with $2.1 million payable at closing and $200,000 one year after.
• Wishpond intends to use the proceeds to reduce its outstanding line of credit by approximately $1.4 million.
• The sale is structured as an asset purchase agreement and does not materially impact Wishpond's core AI-driven marketing platform.

The big picture

What we're watching

Financial Health

The effectiveness of the debt reduction strategy in improving Wishpond’s overall financial stability and access to capital will be a key indicator of management’s strategic direction.

Core Focus

Whether Wishpond can successfully concentrate resources on its core AI-driven marketing platform and achieve anticipated growth without the Viral Loops business remains to be seen.

Acquirer Integration

The success of Emerge Commerce in integrating Viral Loops and realizing synergies will influence perceptions of the deal's value and potentially impact future M&A activity in the referral marketing space.

Event summary

• Organigram Global Inc. secured a C$65.2 million private placement investment from BT DE Investments Inc., a subsidiary of British American Tobacco.
• The investment is linked to Organigram’s acquisition of Sanity Group GmbH, including shares owned by BAT.
• The deal structure includes a C$42.08 million investment at C$3.00 per share and a C$23.12 million top-up at C$2.335854 per share.
• To manage BAT’s ownership, Organigram may issue non-voting Class A convertible preferred shares if BAT’s stake exceeds 30%.

The big picture

What we're watching

Governance Dynamics

The potential issuance of preferred shares to BAT raises questions about the long-term control dynamics within Organigram and BAT’s influence on strategic decisions.

Regulatory Headwinds

The acquisition's success hinges on securing TSX approval and navigating potential regulatory hurdles, which could delay or alter the deal’s structure.

Execution Risk

The integration of Sanity Group and the realization of anticipated synergies will be critical to justifying the investment and demonstrating value creation for Organigram shareholders.

Event summary

• Hims & Hers has agreed to acquire Eucalyptus, an Australian digital health provider, for up to $1.15 billion.
• The acquisition will be financed primarily with existing cash and future operating cash flows, with $240 million payable in cash at closing.
• Tim Doyle, current CEO of Eucalyptus, will become SVP of International at Hims & Hers.
• Eucalyptus has an annual revenue run-rate exceeding $450 million USD and has served over 775,000 customers.
• The deal is expected to close in mid-2026 and is subject to customary closing conditions, including regulatory approvals.

The big picture

What we're watching

Integration Risk

Successfully integrating Eucalyptus's operations and brands into Hims & Hers' existing platform will be crucial, and potential cultural clashes or operational inefficiencies could hinder the deal's value creation.

Regulatory Landscape

The varying regulatory environments in Australia, Japan, Germany, Canada, and the UK pose a significant challenge, and Hims & Hers will need to navigate these complexities to achieve its international expansion goals.

Market Adoption

The pace at which Eucalyptus’s brands and Hims & Hers’ services are adopted by consumers in new international markets will determine the overall success of the acquisition and its impact on profitability.

Event summary

• Cristiano Ronaldo has invested $7.5 million to acquire a 10% equity stake in HBL Pro2col Software, LLC, a Herbalife subsidiary.
• The investment is coupled with Ronaldo’s commitment to provide services and sponsorship rights for Pro2col.
• Pro2col is Herbalife’s digital platform designed for personalized health and wellness, utilizing data and AI.
• Herbalife has initiated a phased beta rollout of Pro2col in the U.S., Canada, and Puerto Rico, with EMEA expansion planned for 2026.

The big picture

What we're watching

Platform Adoption

The success of Pro2col hinges on user adoption beyond the initial beta group; Herbalife must demonstrate tangible value to drive widespread engagement and retention.

Distributor Impact

The platform’s effectiveness in empowering Herbalife’s distributor network will be crucial; Pro2col’s tools must demonstrably improve sales and customer retention to justify the investment.

Regulatory Scrutiny

Given Herbalife’s history with the FTC, Pro2col’s data collection and personalization practices will likely face increased regulatory scrutiny regarding privacy and consumer protection.

Event summary

• Sinch AB resolved to cancel 74,211,294 previously repurchased shares, representing approximately 8.78% of the total outstanding shares.
• The company reduced its share capital by SEK 742,112.94 and subsequently increased it by the same amount via a bonus issue without issuing new shares.
• The capital reduction transfers funds to Sinch’s non-restricted equity.
• The move aims to increase the Board’s flexibility for future share repurchases, authorized until the Annual General Meeting on May 21, 2026.

The big picture

What we're watching

Repurchase Appetite

The Board's willingness to utilize the renewed authorization for share repurchases will signal management's view on Sinch's valuation and future growth prospects.

Equity Management

The transfer of funds to non-restricted equity suggests a potential shift in Sinch's financial strategy, and whether this will be used for acquisitions or other investments remains to be seen.

Shareholder Sentiment

How investors react to this capital structure adjustment, particularly given the bonus issue without new shares, will reveal their expectations for Sinch’s future performance and capital returns.